Back
Viking Therapeutics, Inc. Stock Predictions
Where Smart Money Buys Crypto (Hint: Not Coinbase)
Access Native Markets before the next 100x asset goes mainstream. Watch free training.
Sell
41
VKTX
Viking Therapeutics, Inc.
Last Price:
$35.43
Seasonality Move:
31.11%
7 Day Trial
ALL ACCESS PASS
$
7
Washington Wants Your Money. Here's How to Opt Out.
Learn how to become your own bank. Watch the free training.Viking Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 52.7% based on the past 10 years of stock performance.
-
Viking Therapeutics, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Viking Therapeutics, Inc. Stock Undervalued?The current Viking Therapeutics, Inc. [VKTX] share price is $35.18. The Score for VKTX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 52.7% based on the past 10 years of stock performance.
Viking Therapeutics, Inc. Stock Rating
Sell
41
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. overpriced?
-
Viking Therapeutics, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Viking Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
43.55
52-Week Low:
18.92
Prediction Charts
Market Cap:
4B
Price in USD:
35.18
Volume:
2.1M
Beta:
1.33
Technical Analysis
SMA50:
36.28
SMA100:
32.82
SMA200:
30.43
52-Wk Change:
-13.86%
Stock Predictions
-
Is Viking Therapeutics, Inc. stock public?Yes, Viking Therapeutics, Inc. is a publicly traded company.
-
What is the Viking Therapeutics, Inc. stock quote today?The Viking Therapeutics, Inc. stock price is 35.18 USD today.
-
How to buy Viking Therapeutics, Inc. stock online?You can buy Viking Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-11 | 36.68 | 37.21 | 38.15 | 36.68 |
| Dec-12 | 37.06 | 37.08 | 38.50 | 36.51 |
| Dec-15 | 36.77 | 36.15 | 37.16 | 35.95 |
| Dec-16 | 35.85 | 35.72 | 36.15 | 35.00 |
| Dec-17 | 35.78 | 34.30 | 36.38 | 34.08 |
| Dec-18 | 34.31 | 33.95 | 35.10 | 33.92 |
| Dec-19 | 34.01 | 35.19 | 35.83 | 33.89 |
| Dec-22 | 35.00 | 35.40 | 35.80 | 34.84 |
| Dec-23 | 35.61 | 36.41 | 36.99 | 35.10 |
| Dec-24 | 36.68 | 37.35 | 37.83 | 36.22 |
| Dec-26 | 37.25 | 37.18 | 37.44 | 36.00 |
| Dec-29 | 36.74 | 36.46 | 37.09 | 36.13 |
| Dec-30 | 36.46 | 35.32 | 36.66 | 35.21 |
| Dec-31 | 35.14 | 35.18 | 35.50 | 34.67 |
Viking Therapeutics, Inc. Earnings
Viking Therapeutics, Inc. Earnings Report: Per Share Viking Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics, Inc. Forecast Revenue Growth
Viking Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.31 per share.
* Viking Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.